Faraday Pharmaceuticals
Latest round
- Series A
Last raised
- Jul 2014
Total raised
- Undisclosed
Investors
- 5
About Faraday Pharmaceuticals
Established in 2014 and based in Washington, US, Faraday Pharmaceuticals, Inc. operates as a biopharmaceutical company that focuses on research and development of elemental reducing agents (ERAs) that helps to improve patient's outcomes.
Who invested in Faraday Pharmaceuticals
5 investors across 1 round
See all investors in Faraday Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 8, 2014
Amount
Undisclosed
Investors
Questions about Faraday Pharmaceuticals
Who invested in Faraday Pharmaceuticals?
Faraday Pharmaceuticals has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Faraday Pharmaceuticals raised?
Faraday Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Faraday Pharmaceuticals last raise money?
Faraday Pharmaceuticals's most recent round on record is a Series A, in Jul 2014.
What does Faraday Pharmaceuticals do?
Established in 2014 and based in Washington, US, Faraday Pharmaceuticals, Inc.
Where is Faraday Pharmaceuticals headquartered?
Faraday Pharmaceuticals is headquartered in Seattle, US.
Which VCs invest in companies like Faraday Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Faraday Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Faraday Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.